Compare LSTA & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSTA | BNZI |
|---|---|---|
| Founded | 1980 | 2016 |
| Country | United States | United States |
| Employees | N/A | 28 |
| Industry | Misc Health and Biotechnology Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4M | 15.7M |
| IPO Year | 2000 | N/A |
| Metric | LSTA | BNZI |
|---|---|---|
| Price | $5.02 | $0.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $15.00 | ★ $23.00 |
| AVG Volume (30 Days) | 58.2K | ★ 582.0K |
| Earning Date | 03-12-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.42 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,283,868.00 | N/A |
| Revenue This Year | N/A | $185.61 |
| Revenue Next Year | N/A | $32.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 56.90 | N/A |
| 52 Week Low | $1.81 | $0.54 |
| 52 Week High | $5.07 | $4.44 |
| Indicator | LSTA | BNZI |
|---|---|---|
| Relative Strength Index (RSI) | 70.23 | 33.20 |
| Support Level | $2.31 | $0.83 |
| Resistance Level | $5.07 | $1.14 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 94.69 | 5.37 |
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.